Center Laboratories, Inc. (TPEX: 4123)

Market Cap	36.16B
Revenue (ttm)	1.57B
Net Income (ttm)	-415.44M
Shares Out	720.38M
EPS (ttm)	-0.59
PE Ratio	n/a
Forward PE	n/a
Dividend	1.50 (3.06%)
Ex-Dividend Date	Aug 2, 2024

Volume	4,453,279
Open	49.05
Previous Close	49.05
Day's Range	48.20 - 51.60
52-Week Range	40.10 - 59.60
Beta	0.82
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2024

About Center Laboratories

Center Laboratories, Inc., a pharmaceutical company, engages in the manufacturing and trading of pharmaceuticals in Taiwan and internationally. It engages in the research and development of small molecule drugs, as well as solutions for neurological and oncological diseases; development of proteins and antibodies; and pharmaceutical CDMO, medical device, software as medical device, nutritional health and agribiotechnology, stem cell and immune cell therapy, and industry investment and venture capital businesses. The company also supplies glass ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1959
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4123